ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
43 hedge funds and large institutions have $27.8M invested in Argos Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more capital invested
Capital invested by funds: $25.7M → $27.8M (+$2.06M)
Holders
43
Holding in Top 10
–
Calls
$443K
Puts
$70K
Top Buyers
| 1 | +$1.69M | |
| 2 | +$917K | |
| 3 | +$808K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$700K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$395K |
Top Sellers
| 1 | -$178K | |
| 2 | -$126K | |
| 3 | -$74.6K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$72K |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$62.1K |